DATRON — Facing a distressed market

Datron (DAR)

Last close As at 18/04/2024

USD3.68

0.00 (0.00%)

Market capitalisation

USD663m

More on this equity

Research: Industrials

DATRON — Facing a distressed market

After two years of solid growth, Datron recorded a slight drop in full-year sales in FY19 and a significant decline in EBIT (down by a quarter, year-on-year). This followed a profit warning issued by the management in August 2019 and was driven by worsening market conditions. Due to the high level of uncertainty amid the COVID-19 pandemic, management suspended its full-year guidance in March. Q1 saw a further deterioration in performance. That said, the company maintained a strong balance sheet position (net cash of €8.5m at end-FY19) and has proposed a dividend payout of €0.10 per share from its FY19 earnings, which represents a 1.2% yield.

Milosz Papst

Written by

Milosz Papst

Director, Financials

Industrials

DATRON

Facing a distressed market

Industrials

Scale research report - Update

19 May 2020

Price

€8.30

Market cap

€33m

Share price graph

Share details

Code

DAR

Listing

Deutsche Börse Scale

Shares in issue

4.0m

Net cash at end-FY19

€8.5m

Business description

DATRON is a long-established provider of innovative CNC milling machines, dental milling machines, dosing machines and milling tools.

Bull

Solid balance sheet with minor debt position.

Technologically advanced and innovative.

Recurring income from after sales has been increasing over recent years.

Bear

COVID-19 has exacerbated the existing issues of the sector.

High level of uncertainty over Datron performance in 2020 (with management guidance suspended).

Small size relative to global market.

Analyst

Milosz Papst

+44 (0) 20 3077 5700

After two years of solid growth, Datron recorded a slight drop in full-year sales in FY19 and a significant decline in EBIT (down by a quarter, year-on-year). This followed a profit warning issued by the management in August 2019 and was driven by worsening market conditions. Due to the high level of uncertainty amid the COVID-19 pandemic, management suspended its full-year guidance in March. Q1 saw a further deterioration in performance. That said, the company maintained a strong balance sheet position (net cash of €8.5m at end-FY19) and has proposed a dividend payout of €0.10 per share from its FY19 earnings, which represents a 1.2% yield.

Weakness of core business reflected in FY19 results

Sales were down 3% y-o-y to €53.8m in FY19 (or down 5% y-o-y when adjusted for the first-time consolidation of Datron-Technology Slovakia) while the EBIT margin declined sharply to 7.2% from 9.2% a year earlier. Over the period, the strength of Datron’s international business did not fully compensate for the weak performance of the core Datron machines (including mainly CNC milling) in Germany. Although order intake reduced 3% y-o-y to €53.2m in FY19 (or 5% on adjusted basis), the decline was much milder than the broader German machine tools industry, which recorded a c 22% y-o-y fall over the same period according to VDW (the German Machine Tool Builders’ Association). Q120 saw further deterioration (sales down 9% and EBIT reduced by two-thirds year-on-year), though in line with Datron’s expectations.

COVID-19 intensifies existing sector issues

Management suspended its full-year guidance for 2020 in March 2020 due to uncertainty caused by the COVID-19 outbreak. The sector outlook remains challenging, with the coronavirus pandemic exacerbating existing issues such as trade conflicts and ongoing structural changes. The market has recently faced an unprecedented level of order delays and cancellations as well as continuing disturbances in supply chains. VDMA, the German Mechanical Engineering Industry Association, has withdrawn its forecasts for the sector for 2020, which previously assumed a 5% y-o-y drop in production.

Valuation: Reflecting uncertain outlook

Following a c 33% share price decline since the beginning of the year, Datron is trading at 2019 P/E of 11.9x, which compares with 12.0x for its closest (though much larger) peer Hermle. The proposed dividend of €0.10 per share implies a dividend yield of 1.2% (vs 5.4% for Hermle).

Historical financials

Year
end

Revenue
(€m)

PBT

(€m)

EPS

(€)

DPS
(€)

P/E

(x)

Yield
(%)

12/16

45.7*

2.9

0.52

0.2

16.0

2.4

12/17

50.2

3.9**

0.99

0.2

8.4

2.4

12/18

55.7

5.1

0.87

0.2

9.5

2.4

12/19

53.8

3.9

0.70

0.1

11.9

1.2

Source: Datron data. Note: *Parent company only. **Excludes exceptional gains of €0.9m on sale of business and €0.4m on consolidation.

Edison Investment Research provides qualitative research coverage on companies in the Deutsche Börse Scale segment in accordance with section 36 subsection 3 of the General Terms and Conditions of Deutsche Börse AG for the Regulated Unofficial Market (Freiverkehr) on Frankfurter Wertpapierbörse (as of 1 March 2017). Two to three research reports will be produced per year. Research reports do not contain Edison analyst financial forecasts.

FY19 results reflect challenging market conditions

Datron’s total revenues declined 3% y-o-y to €53.8m in FY19. This is towards the lower end of the company’s guidance of €54–56m, which it revised down in August 2019 (from €60m previously). Total revenues were down c 6% y-o-y when adjusted for c €1.4m attributable to Datron-Technology in Slovakia (together with its subsidiary in Czech Republic), consolidated since 1 January 2019. The decline was coupled with the broader market slowdown as illustrated by a 1% y-o-y drop in total sales for the German machine tools industry in 2019, according to the VDW. We also note that the weaker sales dynamic follows two years of low double-digit growth (c 11% in FY18 and 10% in FY17). We describe the sales development by segment and region below.

Operating expenses remained stable at €51.8m in FY19 as lower material costs compensated for an increase in other operating costs and higher depreciation (upon Datron-Technology consolidation). The former was mainly driven by higher rental/premises costs (after expanding industrial space) as well as an increase in IT spend. As a result, EBIT declined 24% y-o-y to c €3.9m and was therefore marginally below the revised management guidance of €4–5m (vs €6m previously). This translated into an EBIT margin of 7.2%, compared with 9.2% in FY18. EPS was €0.70 vs €0.87 in FY18.

Datron has proposed to pay out a dividend of €0.10 per share for FY19 (vs €0.20 a year earlier). The company had a solid balance sheet at end-FY19, with cash of €9.4m (vs €10.5m at end-FY18) and a minor debt position (€0.9m at end-FY19 vs €0.6 at end-FY18).

Exhibit 1: Financial performance

HGB figures in €m unless otherwise stated

FY19

FY18

Change
y-o-y

Revenue

53.8

55.7

-3%

o/w Datron machines (mainly CNC milling)

33.3

35.7

-7%

o/w CNC/Dental milling tools

10.3

10.8

-5%

o/w After sales and other

9.6

8.7

10%

o/w Other*

0.7

0.5

30%

Change in stocks

1.8

0.6

203%

Other operating income

0.1

0.5

-76%

Material costs

(24.0)

(25.3)

-5%

Personnel costs

(18.0)

(17.9)

1%

Other operating costs

(8.5)

(7.6)

11%

Depreciation

(1.3)

(0.9)

40%

EBIT

3.9

5.1

-24%

Profit before taxes

3.9

5.1

-24%

Income tax

(1.1)

(1.6)

-34%

Net income

2.8

3.5

-20%

EPS (€) - reported

0.70

0.87

-20%

Source: Datron accounts, Edison Investment Research. Note: *Other revenues as per BiLRUG (the German Accounting Directive Implementation Act)

Interestingly, Datron’s order inflow decreased 3% y-o-y to €53.2m in FY19 or 5% y-o-y to €52.0m on an adjusted basis, ie excluding c €1.2m from Datron-Technology. Still, these figures were visibly ahead of the German machine tools industry over the same period, which recorded a c 22% decline in order inflow. Datron’s unadjusted book/bill ratio (excluding purely technical turnover items) was stable at 1.00x at end-FY19 (vs 0.99x a year earlier).

Subdued performance of core segment and market

After a continuing expansion of the installed machine base, aftersales and other revenue recorded a notable 10% growth to €9.6m. As a result, its share in total sales increased to c 18% at end-FY19 (vs 16% a year earlier), which stays in line with management’s strategic objectives, aimed at maintaining and expanding the base of recurring revenues. However, the positive development in the aftersales segment did not compensate for the weaker performance of the core Datron machines segment (including mainly CNC milling), in the domestic market in particular. Over the period, the company sold 310 machines in total (vs 370 in FY18), of which 260 were core Datron machines (down from 290 in FY18). This included over 120 of the DATRON ‘neo’ (vs 150 in FY18) and c 140 of the M8/MLCube (unchanged year-on-year) machines. These declines translated into total sales of Datron machines of €33.3m, down 7% y-o-y. Total sales of CNC and dental tools reduced 5% y-o-y to €10.3m.

Exhibit 2: Revenue split by segment in FY19

Exhibit 3: Revenues by geography

Source: Datron data. Note: Other as per BiLRUG.

Source: Datron data. Note: Excluding other revenues as per BiLRUG

Exhibit 2: Revenue split by segment in FY19

Source: Datron data. Note: Other as per BiLRUG.

Exhibit 3: Revenues by geography

Source: Datron data. Note: Excluding other revenues as per BiLRUG

Over recent years, the company has been making efforts to expand its international business (see Exhibit 3). At end-FY19, it represented c 53% of the total order intake (or 51% of sales), compared with 43% a year earlier (44%). This growth was a function of the buoyancy of international markets (sales up c 12% y-o-y), and a subdued domestic performance (sales down 17% y-o-y). We would also note that 2018’s skew towards Germany was rather a matter of timing, as domestic strength (sales up by a quarter) coincided with delays in completing certain contracts abroad. In FY19, key performance figures in the US, Datron’s second largest single market, were slightly below last year’s levels. Positive drivers in Europe were France, the Netherlands and Sweden, with weaker year-on-year performance in the UK.

It is worth noting that Datron attributes much of its commercial success to the continued high level of R&D spend, which remained broadly stable at €3.8m in FY19 (vs €3.9m in FY18) and represented c 7.5% of its total sales (vs 7% a year earlier). The focus in 2019 was on further development of the control software DATRON ‘next’, integrated into most of the machines the company sells. Moreover, Datron launched a new product, the high-performance CNC milling machine MXCube, in Germany in Q119. Before the COVID-19 pandemic, the company highlighted it may potentially enter new markets with significant growth potential, including e-mobility, fuel cell technology and antenna technology.

Existing sector issues exacerbated by COVID-19

In Q120, Datron sales were down to €11.7m (from €12.8m a year earlier), while EBIT reduced to €0.2m from €0.6m in Q119. This was broadly in line with management guidance released in February 2020 for sales of €11.3–12.8m and EBIT of €0.25–0.5m. In Q120, EPS declined to €0.03 from €0.10 a year earlier. Order intake in the period was €12.2m, which compares with €14.5m in Q119.

Due to COVID-19 uncertainty, the company suspended its guidance for 2020 in March 2020. Before the pandemic, management guided to sales of €53–58m, an EBIT margin of 5–9% and EPS of €0.45–0.90. We believe the subdued management guidance was due to the continuing slowdown of the broader market, affected by trade conflicts and the ongoing restructuring of the industrial sector, including automotive. According to the VDMA, orders in the mechanical engineering sector in Germany declined by another c 2% in Q120 (vs a 9% y-o-y drop in 2019), with a 9% y-o-y decline recorded in March 2020 alone.

The sector outlook remains challenging as COVID-19 has reduced the overall demand and continues to cause disruptions in supply chains. According to VDMA’s survey conducted in May 2020, c 85% of respondents (724 member companies) have recorded a noticeable or serious drop in orders, or cancellations, while two-thirds expected a 10–30% decline in sales in 2020. VDMA has recently suspended its forecasts for a 5% y-o-y drop in production in 2020 released in mid-March 2020 and did not disclose any updated figures due to high market uncertainty and the dynamically changing situation. In mid-April 2020, the IMF expected that the real GDP of Germany would decline by c 7% y-o-y in 2020 and rebound by 5.2% y-o-y in 2021.

Valuation

Datron’s specialisation in milling machines and tools makes for a difficult comparison with listed peers, which are mainly large international players. We believe Datron’s closest peers is Hermle, a German manufacturer of milling machines, though it is also a much larger company as illustrated by its market capitalization of €1bn (vs Datron’s €33m) and annual sales of €463m in 2019 (vs c €54m). We present comparative trading figures for both companies based on 2019 numbers as there is no consensus for Datron and its full year guidance is withdrawn. Datron is trading at a 2019 P/E multiple of 11.9x, which compares with 12.0x for Hermle. The company has proposed to pay a 2019 dividend of €0.10 per share, which implies a yield of 1.2% vs 5.4% for Hermle.

It is worth noting that Hermle has also experienced a subdued performance recently. Its FY19 sales increased 2% y-o-y, order intake reduced by c 13% y-o-y and EBIT margin was broadly stable at c 25%. In Q120, the reduction in Datron’s sales and order intake (down 9% and 16% y-o-y, respectively) was however milder than that for Hermle (down 25% and 36% y-o-y, respectively). At end-April 2020, Hermle warned that its revenues might decline by c 50% y-o-y in FY20 and EBIT is likely to deteriorate disproportionally, affected by the COVID-19 crisis.

General disclaimer and copyright

Any Information, data, analysis and opinions contained in this report do not constitute investment advice by Deutsche Börse AG or the Frankfurter Wertpapierbörse. Any investment decision should be solely based on a securities offering document or another document containing all information required to make such an investment decision, including risk factors. This report has been commissioned by Deutsche Börse AG and prepared and issued by Edison for publication globally.

Edison Investment Research standard fees are £49,500 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright: Copyright 2020 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

1,185 Avenue of the Americas

3rd Floor, New York, NY 10036

United States of America

Sydney +61 (0)2 8249 8342

Level 4, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

.

More on Datron

View All

Industrials

Datron — Benefiting from returning demand

Industrials

Datron — Recovering after a challenging FY20

Industrials

Datron — Market headwinds persist

Industrials

DATRON — Facing a distressed market

Latest from the Industrials sector

View All Industrials content

Research: Healthcare

SymBio Pharmaceuticals — Treakisym label expansion submitted

SymBio announced on 11 May 2020 that it submitted an application to expand the label for Treakisym in Japan to include the treatment of relapsed and refractory diffuse large B-cell lymphoma (DLBCL) in combination with rituximab. This follows the positive results seen in the Phase III study for the combination reported in November 2019. We expect this label expansion to more than double the sales potential for the drug.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free